Hospital & Health Care - Houston, Texas, United States
The Company develops and deploys biosensors with cloud-based analytics that uniquely improve the abilityof an individual to partner with the medical care establishment in anticipating and preventing devastatingdecompensation events. The Company has developed a prototype sensor, Blue Scale, for chronically ill heartfailure patients' use in the home. The Company has designed a clinical trial for the purpose of securingapproval of its product by the FDA.The Blue Scale will further the delivery of therapeutics by providing real-time monitoring and reporting aswell as daily feedback thus improving medication compliance, decreasing complications, preventingdecompensation events, and markedly decreasing the cost of care of this disease that accounts for $39 billionin direct costs. The system will reduce total rehospitalization costs in the U.S. by $6 billion.
WordPress.org
Google Font API
Mobile Friendly